SEHK:1681Pharmaceuticals
Assessing Consun Pharmaceutical Group (SEHK:1681) Valuation After Full Year Earnings Lift Expectations
Full year earnings set the tone for Consun Pharmaceutical Group
Consun Pharmaceutical Group (SEHK:1681) released its full year 2025 results, reporting sales of CNY 3,417.36 million and net income of CNY 1,078.07 million, both higher than the prior year.
Basic earnings per share from continuing operations came in at CNY 1.27, and diluted earnings per share were CNY 1.26, compared with CNY 1.11 and CNY 1.09 respectively a year earlier.
See our latest analysis for Consun Pharmaceutical...